What is it about?
We summarise current knowledge on serum (serological) biomarkers of atherosclerosis. Among novel biomarkers, high sensitivity C-reactive protein (hsCRP) has emerged as the most promising in chronic situations, others need further clinical studies. However, it seems that a combination of serum biomarkers offers more to risk stratification than either biomarker alone.
Featured Image
Read the Original
This page is a summary of: Markers of Atherosclerosis: Part 1 – Serological Markers, Heart Lung and Circulation, May 2019, Elsevier,
DOI: 10.1016/j.hlc.2018.06.1057.
You can read the full text:
Contributors
The following have contributed to this page